Abstract:Background: Type 2 diabetes (T2D) is highly prevalent in British South Asians, yet they are underrepresented in research. Genes & Health (G&H) is a large, population study of British Pakistanis and Bangladeshis (BPB) comprising genomic and routine health data. We assessed the extent to which genetic risk for T2D is shared between BPB and European populations (EUR). We then investigated whether the integration of a polygenic risk score (PRS) for T2D with an existing risk tool (QDiabetes) could improve prediction of incident disease and the characterisation of disease subtypes. Methods and findings: In this observational cohort study, we assessed whether common genetic loci associated with T2D in EUR individuals were replicated in 22,490 BPB individuals in G&H. We replicated fewer loci in G&H (n = 76/338, 22%) than would be expected given power if all EUR-ascertained loci were transferable (n = 101, 30%; p = 0.001). Of the 27 transferable loci that were powered to interrogate this, only 9 showed evidence of shared causal variants. We constructed a T2D PRS and combined it with a clinical risk instrument (QDiabetes) in a novel, integrated risk tool (IRT) to assess risk of incident diabetes. To assess model performance, we compared categorical net reclassification index (NRI) versus QDiabetes alone. In 13,648 patients free from T2D followed up for 10 years, NRI was 3.2% for IRT versus QDiabetes (95% confidence interval (CI): 2.0% to 4.4%). IRT performed best in reclassification of individuals aged less than 40 years deemed low risk by QDiabetes alone (NRI 5.6%, 95% CI 3.6% to 7.6%), who tended to be free from comorbidities and slim. After adjustment for QDiabetes score, PRS was independently associated with progression to T2D after gestational diabetes (hazard ratio (HR) per SD of PRS 1.23, 95% CI 1.05 to 1.42, p = 0.028). Using cluster analysis of clinical features at diabetes diagnosis, we replicated previously reported disease subgroups, including Mild Age-Related, Mild Obesity-related, and Insulin-Resistant Diabetes, and showed that PRS distribution differs between subgroups (p = 0.002). Integrating PRS in this cluster analysis revealed a Probable Severe Insulin Deficient Diabetes (pSIDD) subgroup, despite the absence of clinical measures of insulin secretion or resistance. We also observed differences in rates of progression to micro- and macrovascular complications between subgroups after adjustment for confounders. Study limitations include the absence of an external replication cohort and the potential biases arising from missing or incorrect routine health data. Conclusions: Our analysis of the transferability of T2D loci between EUR and BPB indicates the need for larger, multiancestry studies to better characterise the genetic contribution to disease and its varied aetiology. We show that a T2D PRS optimised for this high-risk BPB population has potential clinical application in BPB, improving the identification of T2D risk (especially in the young) on top of an established clinical risk algorithm and aiding identification of subgroups at diagnosis, which may help future efforts to stratify care and treatment of the disease.

Widespread recessive effects on common diseases in a cohort of 44,000 British Pakistanis and Bangladeshis with high autozygosity

Influence of Autozygosity on Common Disease Risk Across the Phenotypic Spectrum

Investigation of recessive effects of coding variants on common clinical phenotypes in exome-sequenced UK Biobank participants

Genetic architecture of routinely acquired blood tests in a British South Asian cohort

Reproductive and cognitive effects in carriers of recessive pathogenic variants

Genetic associations of protein-coding variants in human disease

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes

RGnet: Recessive Genotype Network in a Large Mendelian Disease Cohort

Distribution and Medical Impact of Loss-of-Function Variants in the Finnish Founder Population

Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study

Determinants of penetrance and variable expressivity in monogenic metabolic conditions across 77,184 exomes

Does Genetic Heterogeneity Account for the Divergent Risk of Type 2 Diabetes in South Asian and White European Populations?

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Rare splice and missense variants with evidence of pathogenicity in consanguineous families with autosomal recessive intellectual disability from Pakistan

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population

Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study

Variations Analysis of 133 Recessive Diseases Carried by 200 Chinese Samples

Phenome-wide Mendelian randomization analysis reveals multiple health comorbidities of coeliac disease

Atlas of human diseases influenced by genetic variants with extreme allele frequency differences

The landscape of autosomal-recessive pathogenic variants in European populations reveals phenotype-specific effects